Successful implantation requires complex signaling between the uterine endometrium and the blastocyst. Prior to the blastocyst reaching the uterus, the endometrium is remodeled by sex steroids and other signals to render the endometrium receptive. In vitro models have facilitated major advances in our understanding of endometrium preparation and endometrial-blastocyst communication in mice and humans, but these systems have not been widely adapted for use in other models which might generate a deeper understanding of these processes. The objective of our study was to use a recently developed, three-dimensional culture system to identify specific roles of female sex steroids in remodeling the organization and function of feline endometrial cells. We treated endometrial cells with physiologically relevant concentrations of estradiol and progesterone, either in isolation or in combination, for 1 week. We then examined size and density of three-dimensional structures, and quantified expression of candidate genes known to vary in response to sex steroid treatments and that have functional relevance to the decidualization process. Combined sex steroid treatments recapitulated organizational patterns seen in vivo; however, sex steroid manipulations did not induce expected changes to expression of decidualization-related genes. Our results demonstrate that sex steroids may not be sufficient for complete decidualization and preparation of the feline endometrium, thereby highlighting key areas of opportunity for further study and suggesting some unique functions of felid uterine tissues.
Introduction
In mammals, successful pregnancy establishment relies upon interactions between the blastocyst and endometrium (lining of the uterus) during implantation [1] [2] [3] . Insufficient endometrial preparation prior to blastocyst arrival is thought to be a major cause of idiopathic pregnancy failure [4] ; if the endometrium is unreceptive to the blastocyst due to incomplete or inappropriate preparation, implantation cannot occur. Development of appropriate interventions to prevent blastocyst rejection relies on a thorough understanding of the processes that lead to endometrial preparedness and maintenance of a permissive environment during early pregnancy.
Endometrial preparation involves both morphological and functional changes that comprise the process of decidualization. Leading up to potential pregnancy, the cells of the endometrium proliferate and reorganize to enlarge the luminal spaces within the endometrium ( Figure 1A , [5] ). Regulatory networks within endometrial cells (ECs) also modify gene expression to promote angiogenesis and glycogen storage. These changes include up-regulation of glucose transporters, receptors for sex steroids (estradiol and progesterone), and angiogenic factors (e.g., vascular endothelial growth factor [Vegf ] ) that will ultimately support placentation. The reorganization of ECs and broad functional changes are superficially conserved among placental mammals [6] [7] [8] [9] [10] [11] , but the underlying mechanisms that coordinate these changes are only well-understood in rodent and human models.
The sex steroids estradiol and progesterone play a major role in many of the functional and organizational changes [5, 12] . For example, elevated progesterone during the late luteal phase and early pregnancy is associated with the elevated transcription of glucose transporter 1 (Glut1) and inhibition of glucose transporter 3 (Glut3) transcription in humans, mice, and rats [13] [14] [15] [16] . However, in vitro studies that have focused on the molecular mechanisms suggest that the direct effects of estradiol and progesterone on endometrial function vary among these species. Although estradiol and progesterone treatment in combination stimulates Glut1 expression [17] [18] [19] [20] , some studies suggest that estradiol alone is responsible for these changes [21] , whereas others suggest that progesterone is principally responsible for Glut1 up-regulation [17] . The same appears to be true for other conserved processes, including angiogenic gene expression. Although estradiol is sufficient to up-regulate Vegf in human EC lines [22, 23] , it has no effect in vitro on Vegf expression in ECs isolated from mice [24] .
Thus far, these taxon-specific mechanisms have principally been used to evaluate the efficacy of rodent models for use in human health research [25] . While these straightforward comparisons are useful for such evaluation, examining diversity in mammalian decidualization using comparative models may help us identify deeply conserved mechanisms of control, thereby improving likelihood of translational success. This approach will aid the development of reproductive technologies for agricultural or conservation applications. Lastly, the development of these in vitro endometrial models is the basis for more complex culture systems used to study blastocystendometrial interactions during early pregnancy and thus lead to advances in basic and applied biology research.
The need for such reproductive tools is especially great for felids. Although much effort has been focused on maintaining the genetic diversity through strategic breeding in captivity, breeding success is very low (<30%) in many endangered species [26, 27] , and intervention development has been slow [26] [27] [28] . Low breeding success may be related in part to aberrant endocrine profiles that sometimes follow ovarian stimulation in felids [26, 29] . Even if follicular maturation and ovulation are successful, atypical endocrine environments may not sufficiently or appropriately prepare the endometrium for receptivity, thus resulting in failed implantation [26, 29] . Identifying the extent to which sex steroids prepare the endometrium for implantation in felids will allow us to identify aspects of an aberrant hormone profile that might contribute to failed reproduction and determine whether manipulating the hormonal profile might improve outcomes in felines and inform broader comparisons among species.
In order to determine the specific and interactive roles of sex steroids on feline endometrial organization and function, we used a recently developed three-dimensional (3D), Matrigel-based culture system for primary ECs from the domestic cat [30] . Matrigel-based culture systems have been used for decades to facilitate cell polarization and organoid growth by ECs in vitro [31] [32] [33] , and primary ECs grown in Matrigel-based matrices form 3D structures that are strikingly similar across mammalian taxa [31] [32] [33] [34] . This system therefore allows us to evaluate both organizational and functional (gene expression) changes to ECs under tightly controlled conditions. We hypothesized that estradiol and progesterone would drive distinct processes related to decidualization-related organization in ways that are consistent with cyclic dominance of each steroid across the natural reproductive cycle ( Figure 1A ). We also hypothesized that the expression of genes relevant to endometrial preparedness in nonfelid mammals [14, [35] [36] [37] [38] [39] would be similarly regulated by estradiol or progesterone in domestic cat ECs.
To test these hypotheses, we first chronically treated replicate cultures with either estradiol or progesterone at physiologically relevant concentrations. We specifically expected to see an increase in the number of gland-like structures in response to estradiol, as occurs in vivo during the follicular phase in domestic cats [6] ( Figure 1B ).
We expected to see an increase in structure size in response to progesterone, as occurs during the luteal phase and in response to exogenous progesterone treatment [6] ( Figure 1D ). We also predicted that estradiol would dose-dependently up-regulate expression of angiogenic genes, including Vegf , but would have no independent effect on Glut3, progesterone receptor (Pgr), or insulin receptor (Ir) expression. In contrast, we predicted that progesterone would upregulate Vegf , Pgr, and Ir and down-regulate Glut3 [36] . Second, we examined the effects of physiologically relevant combinations of sex steroids on these same outcome measures. Many reproductive processes rely on permissive effects of one or more steroids, and we might therefore expect that some changes to EC organization in the endometrium will depend on presence of both sex steroids. However, if sex steroids control truly distinct processes in the endometrium, the morphological organization of ECs should reflect the dominant sex steroid at any given stage and thus be consistent with results from our isolated hormone experiments (shown in Figure 1C and E). We predicted that gene expression patterns would again reflect the dominant sex steroid.
The objective of our study was thus to use a recently developed, mixed cell type 3D culture system to identify specific roles of female sex steroids in remodeling the organization and function of feline ECs.
Materials and methods

Tissue handling and endometrial cell culture
The study did not require the approval of the Animal Care and Use Committees of the Smithsonian Institution or University of California, Berkeley, because reproductive tracts were collected with veterinarian permission during surgeries performed for trap, neuter/spay, and release programs used to manage local feral cat colonies. Whole uterine and ovarian tissues from reproductive queens in the follicular phase were collected into chilled transport media (Table S1 ) immediately following routine spays at local veterinary clinics. EC isolation from uterine horns was carried out within 8 h of tissue collection.
Only uteri from cats in the follicular phase were used for experiments to minimize variation in the luminal environment among samples that occur across the reproductive cycle, including progesteronemediated differentiation of ECs that occurs during the luteal phase. Uterine horns were snipped into ∼ 0.5 cm pieces and washed in ice-cold, sterile Dulbecco's PBS (dPBS, D8537, Sigma-Aldrich). The lumen of each piece was flushed thrice with 100 μL of dissociation solution (1% porcine trypsin [15090046, Gibco] in dPBS) and submerged in dissociation solution. In pilot tests, we found digestion with porcine trypsin resulted in cleaner ECs following isolation compared to digestion with trypsin from bovine pancreas (T9935, Sigma-Aldrich). Tissue was incubated in dissociation solution at 10 • C for 1 h followed by 45 min at room temperature. The digestion was stopped by washing tissue in 20% fetal calf serum (MT35010CV, Corning) in basal media (Table S1 ). Tissue pieces were halved to expose the lumen and then scraped using a scalpel blade to release ECs into media. ECs were transferred to a 35-mm plate containing clean basal medium with 10% FCS and placed on a slide warmer at 38 • C until all tissue segments had been processed. Isolated ECs in ∼ 2 ml of 10% FBS basal medium were moved in solution to 15 ml sterile conical tubes and washed twice with 13 ml of warmed dPBS. For each wash, ECs were suspended in fresh, warmed dPBS and centrifuged for 3 min at 150 g. Supernatant was poured off as waste. After the second wash, all supernatant was removed and replaced with 10 ml of fresh basal medium containing 10% charcoal-stripped FCS (A3382101, ThermoFisher Scientific). ECs were suspended by pipetting up at down with a 1-ml pipette 25 times and plated in 6well plates (353046, Corning). If we found that only a very small number of ECs were isolated from an individual or ECs appeared very contaminated (hazy media or excessive red blood cell retention), the sample was not used for experiments.
ECs were allowed to attach in basal medium for 24 h, at which time medium was removed, wells were gently washed with warmed, sterile dPBS, and medium was replaced with matrigel medium along with treatments (see Table S2 ). Previous work has demonstrated that both epithelial and stromal cells were attached and proliferate in culture; however, the culture is consistently and predominantly (>75%) comprised epithelial cells [30] . Steroid hormones (progesterone [P8783, Sigma-Aldrich] and β-estradiol [E8875, Sigma-Aldrich]) were dissolved in DMSO (D128-500, Fisher Chemical) to generate stock solution aliquots, which were stored at −20 • C until use. Fresh aliquots were thawed and diluted into medium prior to applying treatments to the plates. Vehicle-treated ECs received equivalent amounts of pure DMSO. DMSO concentration was less than 0.01% in culture for all treatments. For experiment 1, we exposed ECs to two concentrations of progesterone or estradiol at physiologically relevant concentrations. For experiment 2, we simulated interestrous (low concentration of both steroids), estrous (high estradiol concentration), and pregnancy (high progesterone) conditions using physiologically relevant concentrations of hormones in combination based on established in vivo measurements in the literature [40] .
Thereafter, medium was replaced every 24-48 h with fresh steroid hormones added to each well. All cultures were carried out in a 38 • C, 5% CO 2 air-jacket incubator. After 7 days, ECs from confluent wells were collected by adding trypsin (0.25% porcine trypsin in preconditioned PBS) for 5 min and scraping ECs from the bottom of the well. Trypsin treatment was halted by addition of 10% charcoalstripped FCS. ECs were moved to 1.5 ml Eppendorf tubes and washed twice with sterile dPBS. After the final wash, all supernatants were removed and replaced with 100 μL of lysis buffer (RLY Buffer, Bioline). ECs were vortexed at room temperature in lysis buffer before storage in −80 • C until ribonucleic acid (RNA) extraction.
Morphological measurements
ECs formed distinct 3D structures in the Matrigel medium ( Figure 2 ). Prior to EC collection from wells, four brightfield images of each well were taken using a stereoscope at fixed magnification from which we quantified the size and density of the two primary types of structures: gland-like ( Figure 2B , arrow heads) and tube-like ( Figure 2B, arrows) . Images were all analyzed in Image J.
The area of gland-like structures was measured in arbitrary units using the freehand tool. Each structure was outlined, and the area was recorded. All structures with an area of larger than 89 μm 2 (100 sq. pixels) were measured, and the number of structures in each image was counted. We counted the total number of tube-like structures that connected two or more gland-like structures. We used the segment tool to measure the diameter at the smallest point along the length of all tubes.
For each well, the number of gland-and tube-like structures were summed across the four images analyzed, and then, a density was calculated by correcting for the total area photographed (the total area of each well imaged varied, e.g., Figure 2B and C). 
Real time wuantitative polymerase chain reaction
RNA was extracted using the Bioline RNA Micro Kit according to manufacturer guidelines (BIO-52075, Bioline). 750 ng of RNA were reverse transcribed to cDNA in a 40-μL reaction using the BioRad gDNA-clear reverse transcription for qPCR kit (BioRad 1725035). Each sample was assayed in triplicate, 12 μL quantitative PCR reactions in 384-well plates on a BioRad CFX 384 Touch Real-Time PCR Detection System. All primers were validated for specificity (using melt curves and agarose gel) and efficiency (standard dilution curve) prior to use. Primer sequences, concentration used in reactions, annealing temperatures, and efficiencies are listed in Table S3 .
Experimental design and sample sizes
For each experiment, ECs from each individual were evenly allocated among 6 wells in one 6-well plate (i.e., ECs isolated from individual X were evenly allocated among 6-well plate A, and ECs from individual Y were evenly allocated among 6-well plate B, etc.). For experiment 1, one of the six wells was not used for further experimentation, and the five remaining wells were assigned to each of the five treatment groups (Table S2) . For experiment 2, three wells were assigned to treatment groups from experiment 1 (VEH, E 2 H, and P 4 H), and the other three wells were assigned treatments for experiment 2 (IE, Es, and Pr; see Table S2 ). Of 111 total wells plated from 20 unique individuals, three wells were not included in further analyses due to yeast contamination during the culture period. Morphology of five wells were not analyzed because images were not captured prior to collecting ECs from wells. Finally, sample sizes for gene expression data are smaller because ECs were collected only from a subset of plates. Resulting sample sizes are summarized in Table S2 .
Statistical analysis
Differences in morphological measures of EC organization were analyzed using a generalized linear model approach (glmer). Model fit was evaluated using QQ plots. Treatment was included as fixed effects, with a random effect of individual ID nested within isolation date. For gland-like area, an inverse Gaussian distribution with identity link was fit to untransformed data. For tube diameter, a gamma distribution with log link was fit to untransformed data. For gland-and tube-like structure density, a gamma distribution with log link was fit to untransformed data. Significant differences among groups were determined using Tukey's HSD post-hoc testing (P < 0.05).
For gland-like structure area, we plotted estimated marginal means, which normalize values among random effects (ID and date of isolation), as generated by the emmeans package.
Relative gene expression for each gene was calculated using the Pfaffl method with single-run efficiency corrections based on a standard curve generated from pooled samples [41] . For experiment 1, all reference genes showed a significant effect of treatment on expression when including the vehicle-control wells (P < 0.06 for all). We therefore removed the vehicle control and used the 4 pg/ml estradiol treatment (E 2 L) as our reference group for calculations and figures related to gene expression in experiment 1. For experiment 2, the interestrous-like treatment (IE) was used as the reference group. Thus, in figures, gene expression is shown as fold-change over the average expression in E 2 L-or IE-treated wells.
Gene expression was normalized relative to the geometric mean of two reference genes (Ywhaz and Rpl2) that did not vary with treatment (P > 0.30). We rank-transformed all gene expression measures prior to analysis to ensure residual normality. Treatment effects were estimated using a generalized linear model with a Gaussian distribution, and log link. Treatment was included as the fixed effect and individual ID nested within isolation date as the random effect. Goodness of fit was assessed using QQ plots for all models. Significant differences among treatment groups were determined using Tukey's HSD post-hoc testing (P < 0.05).
Plots show mean ± SE.
Results
Do female sex steroids independently modify EC organization and gene expression?
EC organization. Steroid treatment did not alter the density of glandlike structures ( Figure 3A , TRT: F 4,65 = 2.36, P = 0.06), but it modified gland-like structure areas ( Figure 3B , TRT: F 4,2700 = 23.87, P < 0.0001). Both estradiol treatments and 4 ng/ml progesterone treatment significantly decreased the average gland-like structure area ( Figure 3B , P < 0.0001 for all), whereas 40 ng/ml progesterone treatment resulted in average gland-like structure area that did not differ from vehicle-treated controls ( Figure 3B vs. E 2 H, z ratio = 5.70, P < 0.0001), whereas progesterone had no effect on density of tube-like structures ( Figure 3C , P > 0.36 for all comparisons). Steroid treatment had no effect on average diameter of tube-like structure ( Figure 3D , TRT: F 4,540 = 1.69, P = 0.15).
Relative gene expression.
There was no difference in the expression of Glut3 (Figure 4A , F 3,46 = 0.86, P = 0.47). All other genes were affected by steroid treatment (Vegf : Figure 4B , F 4,46 = 3.43, P = 0.02; Pgr: Figure 4C , F 4,46 = 7.99, P = 0.0002; Ir: Figure 4D , F 4,46 = 4.13, P = 0.01). Vegf expression was higher in the 4 ng/ml progesterone treatment compared to the 40 pg/ml estradiol treatment (z ratio = −3.06, P = 0.01), but not significantly higher than the 40 ng/ml progesterone treatment (z ratio = −2.43, P = 0.07).
Pgr expression was higher in the 40 pg/ml estradiol treatment compared to all other treatments (P < 0.02 for all comparisons) but did not differ among remaining treatments (E 2 L, P 4 L, P 4 H; P > 0.031 for all comparisons). Finally, Ir expression was higher in the 4 ng/ml progesterone group relative to the 40 pg/ml estradiol group (z ratio = −3.31, P = 0.005), and the 4 pg/ml estradiol and 40 ng/ml progesterone were intermediate (P > 0.19 for all other comparisons).
Do female sex steroids modify EC organization and gene expression in physiologically relevant combinations?
EC organization. Gland-like structure density varied among in vivolike steroid conditions ( Figure 5A , TRT: F 2,30 = 3.61, P = 0.04).
Relative to low steroid conditions in the interestrous-like (IE) group, high estradiol conditions (estrous-like, Es) decreased the gland-like structure density ( Figure 5A , z = −2.95, P = 0.009), and highprogesterone conditions (pregnancy-like, Pr) resulted in an intermediate gland-like structure density ( Figure 5A , P > 0.12 for all comparisons). Gland-like structure area also varied among combined treatments ( Figure 5B , TRT: F 2,944 = 7.51, P = 0.0005). In this case, gland-like structure areas in the Pr treatment were larger than the IE treatment (z ratio = −3.65, P = 0.0008), while Es treatment gland-like structure areas were intermediate in size (P > 0.08 for all comparisons). The density of tube-like structures varied among treatments ( Figure 5C , TRT: F 2,30 = 8.40, P = 0.001). The density of tubelike structures was lowest in the Es treatment ( Figure 5C , vs. IE, z ratio = −4.45, P < 0.0001; vs. Pr, z ratio = −2.42, P = 0.04), and there was no difference in tube-like structure density between Pr and IE treatments (z ratio = 1.95, P = 0.12). Treatment had no effect on tube-like structure diameter ( Figure 5D , TRT: F 2,107 = 1.08, P = 0.34).
Relative gene expression.
There was a significant effect of treatment on expression of Glut3 ( Figure 6D , TRT: F 2,18 = 9.90, P = 0.001) and expression of Vegf ( Figure 6D , TRT: F 2,18 = 6.22, P = 0.008). There was no effect of treatment on expression of Pgr ( Figure 6D , TRT: F 2,18 = 2.65, P = 0.09) or Ir ( Figure 6D , TRT: F 2,18 = 1.56, P = 0.24).
Expression of Glut3 was lowest in the Pr treatment group (Figure 6A , Pr vs. Es, z ratio = 3.32, P = 0.002; Pr vs. IE, z ratio = 4.47, P < 0.0001). The same pattern was evident in Vegf expression ( Figure 6B , Pr vs. Es, z ratio = 2.89, P = 0.01; Pr vs. IE, z ratio = 3.49, P = 0.001).
Discussion
Sex steroids are associated with changes to function and organization of the ECs that are requisite for successful pregnancy. We explored the extent to which sex steroids modify the organization and function of primary feline ECs in vitro. Our experiments are the first to demonstrate that 3D structures formed by ECs in Matrigel are responsive to physiologically relevant hormone regimes, and thus, we offer novel evidence for the relevance of these structures to in vivo EC organization. We also found that sex steroids enact different patterns of effects on EC organization vs. EC function (gene expression), which suggest that there may be distinct regulatory systems within the felid endometrium responsible for decidualization-like processes. Our experiments lay the groundwork for more comparative experimentation on the mechanisms controlling uterine preparedness in mammalian models while also proposing novel hypotheses about endocrine control of the endometrium in felids.
EC organization reflects antagonistic interactions between sex steroids
ECs organize into similar 3D structures in vitro across species [31] [32] [33] [34] , and researchers often compare their histological similarity in structure to the glands that form and grow in the endometrial epithelium during pregnancy preparation in vivo [31] [32] [33] [34] . To our knowledge, no one has experimentally determined whether the abundance or size of these structures varies with sex steroid treatment as would be expected based on in vivo patterns (e.g., Figure 1A , [6, 42] ). Thus, even though the organization at the cellular level resembles endometrial glands, the extent to which their formation reflects biologically relevant processes remains untested. Based on in vivo associations [6, 35, 39, 42, 43] , we had predicted that estradiol would be associated with increased number of structures ( Figure 1B and C) . We instead found that estradiol and, to a lesser extent, progesterone exerted suppressive effects on structure number (relative to vehicle-controls, Figure 3A and C; Figure 5A and C). Interestingly, these effects were more pronounced in tube-like structures, though the pattern is apparent for both gland-and tube-like structures. The functional implications of differences between tube-and gland-like structure sensitivity to sex steroids is not clear because all previous research has focused on gland-like structures only. An in vivo structure equivalent to these tube-like structures has not been determined based on histological comparisons of cell organization. However, we did observe that their diameter appears largely fixed across sex steroid treatments, suggesting that their organization and growth is distinct from the gland-like structures. Without more detailed information on form (cell polarity and structure within the tube), it is difficult to discern their functional and biological relevance.
We had predicted that progesterone would increase structure size, but we found limited support for this hypothesis. Instead, both estradiol and progesterone exposure largely resulted in smaller gland-like structures relative to the vehicle control ( Figure 3B ). Interestingly, we find exceptions to these suppressive effects of sex steroids in the pregnancy-like treatment containing both sex steroids, where the combination of progesterone and estradiol appears to partially "rescue" the tube-and gland-like structure density as well as glandlike structure size. That the absence of sex steroids in vitro results in the largest and most abundant 3D structures challenges the idea that sex steroids actively promote the increase in structure number and size to support early pregnancy. Instead, our results suggest that progesterone at high concentration is permissive to endometrial reorganization, likely by counteracting effects of estradiol. In this scenario, the differences in gland area in Figure 3B reflect absence of action of progesterone at high concentration, rather than an active promotion of gland size. Thus, hormone treatments that modify the estradiol/progesterone ratio are likely to modify the preparatory organization of the uterine endometrium prior to pregnancy. By recapitulating some-but not all-predicted changes to EC organization under physiologically relevant sex steroid concentrations, our study suggests that in vitro models are an appropriate way to further explore the underlying processes. In vitro models would be particularly useful to understand the balance between apoptosis and proliferation that allows for cellular reorganization within the endometrium. 
Glut3 regulation by progesterone is largely conserved in feline ECs
Overall, we found limited support for our hypothesis that sex steroids in isolation would exert similar effects on gene expression when administered in combination. In particular, despite evidence that progesterone suppressed Glut3 expression in the endometrium of humans [14] , mice [16] , rats [15] , and cats [35] , we found no independent effect of either sex steroid on Glut3 expression ( Figure 3A) ; instead, suppressive effects of progesterone on Glut3 expression were only apparent when both sex steroids were combined, but progesterone was high ( Figure 5A ). Taken together with the results on EC organization described above, the ratio of estradiol to progesterone (within a biologically relevant range) maybe a more informative metric for integrating in vitro and in vivo findings and generating mechanistic hypotheses to describe endometrial preparation.
Sex steroids do not modulate expression of decidualization-related markers in felid ECs
Surprisingly, we did not find any evidence for the up-regulation of classic markers of decidualization, Vegf and Pgr, under any conditions. In fact, the combined steroid treatment we expected to be most likely to promote Vegf and Pgr transcription (pregnancylike, Pr) resulted in a significant suppression of Vegf expression and a nonsignificant decrease in Pgr expression ( Figure 6B and C) . These genes are reliable markers for decidualization in canines and felines [37, 39, 44] , and combined treatment with estradiol and progesterone is routinely effective for sustaining high expression of Vegf in human ECs in vitro [22, 23] . Several possibilities could explain this striking difference. Most simply, failure to detect a decidualization response through these gene markers could reflect a relatively short window during which these genes are up-regulated under chronic treatment, and our sampling time point was simply past this critical window. In this case, quantifying gene expression after shorter-term treatment and/or protein abundance later in the culture period would be needed to determine whether feline ECs displayed a classic decidualization response in vitro. However, because these changes to gene expression reflect differentiation processes at the level of the cell and remain apparent over a week after chronic treatment in human ECs, we believe this is not the most likely explanation for our results.
Alternatively, these differences could reflect fundamentally unique aspects of felid biology. One such possibility is that decidualization-related changes to gene expression might be particularly dependent on prior differentiation processes that only occur under other steroid environments (i.e., Es-like conditions). In this case, measuring decidualization-related changes in gene expression would require that treatment administration recapitulate natural transitions in the endocrine environment. Taking such a dynamic approach to the culture system would be an exciting way to test this hypothesis.
The failure to detect a decidualization response by way of established markers could also suggest that the decidualization process and/or the signals that stimulate decidualization are unique within felids. Still, decidualization markers including Vegf are locally upregulated in feline uteri in vivo [39] , so up-regulating the expression of Vegf is probably a conserved part of the feline decidualization response. In contrast, primary canine ECs also failed to up-regulate Pgr as part of decidualization [37] , though immortalized canine ECs did express subtle changes in Pgr expression during decidualization [38] . Defining a useful suite of decidualization markers for felines may therefore require a broader approach (e.g., microarray oromics) to identify prominent markers.
Feline EC organization and gene expression reflect distinct integration pathways
When considered together, our gene expression results most clearly emphasize the importance of interactions between progesterone and estradiol signaling-gene expression under isolated steroids did not predict differential gene expression when steroids were combined for any of the gene transcripts we examined. These results stand in somewhat sharp contrast to our results regarding EC organization, where the effects of estradiol and progesterone when isolated were informative for understanding the results from combined treatments. Understanding whether these differences are reflections of truly distinct organizational and functional regulatory processes or a product of observing variation at different levels of biological organization remains to be tested. The molecular mechanisms that modify EC organization (e.g., production and localization of cell adhesion proteins) in felines remain largely unknown but identifying these markers and examining their response to sex steroids will be particular informative for integrating the organizational and functional results presented here.
Our experiments suggest that 3D structures formed by feline ECs in vitro and some gene markers are indeed responsive to sex steroids in predictable ways, but they also highlight remaining unknowns. Based on our reported interactive effects of progesterone and estradiol, varying the ratio of progesterone to estradiol as well as the concentration of each across a range will likely lead to important insight into the relative role of each. The simpler approach of isolated sex steroid treatments appears to yield limited insight into felid EC function. Mixed sex steroid manipulations will be especially important for understanding the mechanisms that might underlie reproductive failure. We can use known ratio and values of sex steroids along with the known reproductive outcomes from in vivo reproductive attempts to understand more specifically which organizational and functional changes to ECs might be most important for success.
Because the set of signals that leads to decidualization in felines is poorly defined, exploring the contribution of other hormones to the organization and function of feline ECs will be an important line of future research. A complex suite of factors may be necessary to coordinate the organizational and functional aspects of decidualizationrelated reorganization of the felid endometrium, perhaps through modulating sensitivity to sex steroids.
Conclusions
By defining the role for sex steroids in preparing ECs for pregnancy, we have taken several steps toward understanding EC regulation and advanced the broader application of these techniques to complex culture systems. Combining these approaches with established in vitro fertilization technologies (e.g., [45, 46] ) will allow us to interrogate implantation failure more directly by combining known-quality blastocysts with ECs that are differentiated under various endocrine environments. Ultimately, these lines of research will allow us to exert targeted control over specific mechanisms and thus improve in vivo reproductive success rates. By approaching these goals from a comparative perspective to identify conserved function, we increase the likelihood that mechanisms emerging from this work will be efficient and adaptable, ultimately leading to improvements to both animal and human health.
